- Conditions
- TOR1A, PANK2, HPRT1, EIF2AK2, SOX2, KMT2B, GABRB2, ADCY5, UBA5, GNAO1, SGCE, TNPO2, GNB1, PLA2G6, Movement Disorders, Dystonia, Chorea
- Interventions
- Not listed
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- Not listed
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Apr 12, 2026 · Synced May 22, 2026, 5:36 AM EDT